Deborah Cohen, Ph.D., is elected to prestigious National Academy of Medicine

Research led by Mark Slifka, Ph.D., finds HIV patients being treated with antiretroviral therapy lose their immunity to smallpox despite having received a childhood vaccination against the disease.

Research led by Nancy Haigwood, Ph.D., finds a single dose of antibodies given 30 hours after viral exposure can prevent infection in baby rhesus macaques born to HIV-positive mothers.

STAT article about how the high cost of multiple sclerosis medicines is forcing many patients to take ‘drastic actions.’

OHSU Knight Cancer Institute researchers contribute to Nature Biotechnology paper outlining a new framework to estimate how fast an individual cancer has evolved using open-source software.

Alan Teo, M.D., and colleagues publish new definition of hikikomori, or extreme isolation, to improve the recognition and treatment of the condition.

Molly Hubbard, M.D., a pediatric neurosurgery fellow recently hired as a faculty member, died this week in an avalanche while skiing near Kellogg, Idaho.

Blueprint Medicines announces FDA approval of AYVAKIT, a drug for patients with a form of gastrointestinal stromal tumor, or GIST; study investigator Michael Heinrich, M.D., says: “Building on our growing understanding of the molecular basis of GIST, this milestone ushers in a new era of precision medicine in this disease.”

Knight Cancer Institute volunteer Sherry Hanson writes a piece for CURE on the importance of communicating with those going through cancer treatment.

Esther Choo, M.D., is one of several national experts asked to predict what’s next for their respective industry’s workplace.